Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia

作者
Fabio Gil,Fabián Juliao Baños,L Alvarez Amador,Natalia Castaño-Gamboa,Juan Manuel Reyes
出处
期刊:PharmacoEconomics - open [Adis, Springer Healthcare]
卷期号:6 (6): 837-846 被引量:4
标识
DOI:10.1007/s41669-022-00360-4
摘要

OBJECTIVE: The aim of this study was to evaluate the cost effectiveness of tofacitinib versus other treatment options currently available in Colombia in naïve to biologics (first-line) and exposed to biologics (second-line) patients with moderate to severe active ulcerative colitis (UC). METHODS: A Markov model was constructed with 8-week cycles, simulating a cohort of patients in a 5-year time horizon. The health states included remission, treatment response, active UC, and colectomy. The transition probabilities for the induction and maintenance phase were obtained from a network meta-analysis, and effectiveness was measured using quality-adjusted life-years (QALYs). Unit costs were derived from official national sources. RESULTS: For first line, the incremental cost-effectiveness ratio (ICER) per QALY was $883 for tofacitinib and $3619 for infliximab, compared with adalimumab. Sensitivity analysis showed that tofacitinib is cost effective in 45% of the iterations, adalimumab in 5%, and infliximab in 50%. Meanwhile, the ICER of adalimumab was $14,927 compared with tofacitinib in second-line treatment. In the sensitivity analysis, tofacitinib was cost effective in 64% of the iterations, followed by adalimumab in 36%. Infliximab and golimumab were not included due to data limitations in the network meta-analysis of second-line treatment. CONCLUSION: The analysis suggests that in Colombia, treatment with tofacitinib for patients with moderate-to-severe UC is a cost-effective option in both lines compared with other treatment options.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI65的应助被谦让的斓采纳,获得10
刚刚
寞失完成签到,获得积分10
1秒前
饱满的雍完成签到,获得积分10
1秒前
葡萄冻冻发布了新的文献求助10
2秒前
yemmmmd发布了新的文献求助10
2秒前
慕青的应助被缥缈的海亦采纳,获得10
2秒前
3秒前
无花果的应助被ZZ采纳,获得10
3秒前
3秒前
等待采白发布了新的文献求助10
3秒前
1123qwq发布了新的文献求助10
4秒前
靓丽谷南完成签到 ,获得积分10
5秒前
5秒前
5秒前
zxldylan完成签到,获得积分10
6秒前
羊小驼完成签到,获得积分10
6秒前
7秒前
7秒前
修狗叫大黄完成签到,获得积分10
7秒前
fanghaoxiang发布了新的文献求助10
7秒前
Spring完成签到,获得积分10
7秒前
Xin发布了新的文献求助10
7秒前
8秒前
chy关闭了chy的文献求助
8秒前
9秒前
斯文哈密瓜完成签到 ,获得积分10
9秒前
9秒前
何yezi完成签到 ,获得积分10
9秒前
wzxxxzzzxxxxz发布了新的文献求助10
10秒前
追寻盼旋完成签到 ,获得积分10
10秒前
Elsevier大王的应助被谦让的斓采纳,获得30
12秒前
12秒前
12秒前
13秒前
Hello的应助被健壮的化蛹采纳,获得20
14秒前
科研通AI6.2的应助被qqqqqqqqqq采纳,获得10
15秒前
不安的半梦完成签到,获得积分10
15秒前
饱满的雍发布了新的文献求助10
15秒前
秋风的应助被Xin采纳,获得150
15秒前
he发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264